Literature DB >> 6241542

Biologically active complement (C5)-derived peptides and their relevance to disease.

H D Perez.   

Abstract

In man and in most mammals, activation of the complement system via either the classical or the alternative pathway results in the generation of biologically active peptides. The most active peptides are C5a and C5a des Arg generated by cleavage of the alpha-chain of native C5. C5a is a potent anaphylatoxin and can induce human polymorphonuclear leukocytes to migrate in a directed fashion, to degranulate, to undergo a burst of oxidative metabolism and to aggregate. Upon generation C5a is converted in serum and plasma to C5a des Arg with loss of the noxious anaphylatoxin activity. C5a/C5a des Arg play important roles in host defenses against bacterial infections and possibly in the mediation of some pathologic lesions such as the leukocyte infiltration seen in the lungs during acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6241542     DOI: 10.1016/s1040-8428(84)80012-8

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  4 in total

1.  Early gestation chorionic villi-derived stromal cells for fetal tissue engineering.

Authors:  Lee Lankford; Taryn Selby; James Becker; Volodymyr Ryzhuk; Connor Long; Diana Farmer; Aijun Wang
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

2.  Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity.

Authors:  H D Perez
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

3.  Human genes for complement components C1r and C1s in a close tail-to-tail arrangement.

Authors:  H Kusumoto; S Hirosawa; J P Salier; F S Hagen; K Kurachi
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

Review 4.  Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.

Authors:  Helen Ha; Bikash Debnath; Nouri Neamati
Journal:  Theranostics       Date:  2017-04-07       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.